CFSAN-2024-122588-Purchase of a Gen1000 and a Gen2000 growth chambers

The purpose of this amendment is to cancel this notice in its entirety. The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) does not wish to pursue this requirement to procure: this listed items, "as is", at this time. A future notice may be posted subsequently, if the need arises.